UK: +44 (0) 1283 753 220
US: +1 908 829 4146
The North 51 founders – Phil Randall, Paul Dermody and Oliver Jackson believe that this exciting development presents North 51 with new opportunities for growth, both in the UK and internationally; especially as Bionical do not currently provide any of the services that North 51 offers and are keen to invest in the future of the business.
Founded in 2004, North 51 has since grown organically to employ almost 150 people. Via 3 Divisions North 51 delivers recruitment and contract sales solutions to the pharmaceutical industry, creates digital experiences and software products for organisations across the healthcare sector and runs outsourced Public Health services for the NHS and Local Authorities.
Bionical is a fast growing international business based locally in Derbyshire, also specialising in the healthcare sector. Bionical’s core business is in Clinical Trial Services and the acquisition of North 51 is their second such acquisition in the last few months, having acquired the US based company, McCallan, in July. McCallan are based just south of New York and specialise in pharma engagement, particularly with Primary Healthcare Professionals.
Graham McIntosh – CEO at Bionical said “The acquisition of North 51 enhances Bionical’s commitment to helping Healthcare companies truly engage with their customers be that patients, physicians or payers.”
Phil Randall - CEO at North 51 said “The North 51 Directors are delighted with this development. Our discussions with Bionical left us in no doubt that this acquisition would open up a new and exciting phase for North 51 and create many exciting opportunities for our staff.”
Paul Dermody - MD at North 51 said - “North 51 is very proud to join forces with Bionical. Working together will enable us to develop new and innovative solutions that can only improve the services we offer and provide to our clients.”
All rights reserved © 2019 Bionical Ltd.